SUGAMMADEX SODIUM
REVERSAL OF NM BLOCKING-SELECTIVE RELAXANT BINDING TYPE
Hikma Pharmaceuticals USA
Drug class
Reversal of NM Blocking-Selective Relaxant Binding Type
The therapeutic category "Reversal of NM Blocking-Selective Relaxant Binding Type" refers to selective relaxant binding agents, a specialized class of neuromuscular blockade reversal drugs represented primarily by sugammadex. Read more about Reversal of NM Blocking-Selective Relaxant Binding Type
22 drugs in this class 20 manufacturers
Drugs in Reversal of NM Blocking-Selective Relaxant Binding Type
SUGAMMADEX SODIUM
REVERSAL OF NM BLOCKING-SELECTIVE RELAXANT BINDING TYPE
PAR HEALTH USA,
SUGAMMADEX SODIUM
REVERSAL OF NM BLOCKING-SELECTIVE RELAXANT BINDING TYPE
FRESENIUS KABI
SUGAMMADEX SODIUM
REVERSAL OF NM BLOCKING-SELECTIVE RELAXANT BINDING TYPE · REVERSAL OF NEUROMUSCULAR BLOCKADE INDUCED BY ROCURONIUM ·+1
FOSUN PHARMA US
Filter & compare in the drug finder →
Opens the drug finder with Reversal of NM Blocking-Selective Relaxant Binding Type preselected. Add indication or manufacturer filters there.
The therapeutic category "Reversal of NM Blocking-Selective Relaxant Binding Type" refers to selective relaxant binding agents, a specialized class of neuromuscular blockade reversal drugs represented primarily by sugammadex.
These agents work by physically encapsulating free aminosteroid nondepolarizing neuromuscular blocking drugs—specifically rocuronium and vecuronium—in a 1:1 molecular complex within plasma, rendering them inactive and rapidly restoring normal muscle function without altering acetylcholinesterase activity.
Clinically, they are indicated in surgical anesthesia and critical care to reverse shallow to profound neuromuscular paralysis, preventing postoperative residual weakness and facilitating safe extubation.
-
connectrx.com
The therapeutic category "Reversal of NM Blocking-Selective Relaxant Binding Type" refers to selective relaxant binding agents, a specialized class of neuromuscular blockade reversal drugs represented primarily by sugammadex
-
nih.gov
The therapeutic category "Reversal of NM Blocking-Selective Relaxant Binding Type" refers to selective relaxant binding agents, a specialized class of neuromuscular blockade reversal drugs represented primarily by sugammadex
-
xenonhealth.com
The therapeutic category "Reversal of NM Blocking-Selective Relaxant Binding Type" refers to selective relaxant binding agents, a specialized class of neuromuscular blockade reversal drugs represented primarily by sugammadex
-
managedhealthcareexecutive.com
These agents work by physically encapsulating free aminosteroid nondepolarizing neuromuscular blocking drugs—specifically rocuronium and vecuronium—in a 1:1 molecular complex within plasma, rendering them inactive and rapidly restoring normal muscle function without altering acetylcholinesterase activity Clinically, they are indicated in surgical anesthesia and critical care to reverse shallow to profound neuromuscular paralysis, preventing postoperative residual weakness and facilitating safe e...
-
nih.gov
These agents work by physically encapsulating free aminosteroid nondepolarizing neuromuscular blocking drugs—specifically rocuronium and vecuronium—in a 1:1 molecular complex within plasma, rendering them inactive and rapidly restoring normal muscle function without altering acetylcholinesterase activity
-
pshp.org
These agents work by physically encapsulating free aminosteroid nondepolarizing neuromuscular blocking drugs—specifically rocuronium and vecuronium—in a 1:1 molecular complex within plasma, rendering them inactive and rapidly restoring normal muscle function without altering acetylcholinesterase activity
-
pharmacypracticenews.com
Clinically, they are indicated in surgical anesthesia and critical care to reverse shallow to profound neuromuscular paralysis, preventing postoperative residual weakness and facilitating safe extubation
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.